Made-in-India- Nose vaccines, made in India, can be a game changer for children. However, it may not be available this year, says World Health Organization senior scientist Soumya Swaminathan. Hope comes amid concerns over a third visible coronary wave of the coronavirus that has plagued children.
“Some of the nasal vaccines that will be developed in India would be to change children’s play – which is easy to carry, it will give the immune system a respiratory tract,” said Swaminathan, a pediatrician in an exclusive interview with CNN-News18 Made-in-India.
Made-in-India-However, he emphasized that until then, more and more adults, especially teachers, needed to be vaccinated and schools were reopened only when the risk of public transmission was low. “I have high hopes that we will finally have a vaccine for children. But that will not happen this year, and we should open schools where public transfers do not work. That is what some countries have done, in some ways to protect themselves. And if teachers are vaccinated, that could be a big step forward, “said a WHO senior scientist.
The center on Saturday said children were not immune to the disease, but emphasized that the impact was small. “If children are affected by Covid, there may be no symptoms or little symptoms. They do not need to be hospitalized in general, “said Niti Aayog (health) member VK Paul during a press conference at the Union Department of Health.
He also added that health infrastructure should be upgraded to treat Covid-19 in children, but it is very important not to allow them to be part of the transmission chain.
Children account for about 3-4 percent of hospital admissions, in India and around the world, Paul said, adding that special care should be given to those between the ages of 10 and 12 as they travel extensively.
Prime Minister Narendra Modi, in a recent meeting with state and regional officials, called on them to gather information on disease transmission and empowerment of youth and children.
The US Food and Drug Administration has already issued emergency approval for the Pfizer-BioNTech vaccine for young people aged 12 to 17 years. Reports said two more drugs could be given emergency approval for children in the coming months. Moderna is testing its vaccine on 3,000 children aged 12 to 17 and may have side effects for that age group within weeks. Johnson & Johnson in April also began reading to 12- to 17-year-olds, the New York Times reported.
“Many vaccine manufacturers have started testing their children, as the Pfizer vaccine is now approved for children over the age of 12 and tests for young children are ongoing. It is expected that in a few months, Pfizer and Moderna drugs will be approved. AstraZeneca and other drugs for young people – there is a slow progress there due to the rare side effects noted in the new generation given adenoviral vaccines. But there will definitely be more vaccines, “Swaminathan said.
Pfizer also has plans to seek emergency authorization in the US in September for children between the ages of 2 and 11, as well as the results of a modern clinical trial in children as young as six months expected by the end of the year.
